Effect of Glucose or Fat Challenge on Aspirin Resistance in Diabetes
2010

How Glucose and Fat Affect Aspirin Resistance in Diabetics

Sample size: 55 publication Evidence: moderate

Author Information

Author(s): Yassine Hussein N., Davis-Gorman Grace, Stump Craig S., Thomson Stephen S., Peterson Justin, McDonagh Paul F.

Primary Institution: Arizona Health Sciences Center, University of Arizona

Hypothesis

The study aims to investigate the roles of acute hyperglycemia and hyperlipidemia on aspirin function in diabetic subjects with and without cardiovascular disease.

Conclusion

Saturated fat ingestion increases in vivo thromboxane production despite aspirin therapy.

Supporting Evidence

  • Aspirin has lower antiplatelet activity in diabetic patients.
  • Urine thromboxane increased significantly after fat ingestion.
  • Diabetic subjects with cardiac disease showed increased thromboxane after glucose ingestion.

Takeaway

Eating a lot of fat can make aspirin less effective for people with diabetes, which is important to know for heart health.

Methodology

The study involved 55 diabetic subjects who underwent either a glucose or fat challenge while on aspirin therapy, measuring urine thromboxane and VerifyNow responses.

Potential Biases

The absence of a control group may introduce bias in interpreting the results.

Limitations

The study has a small sample size and lacks a control group.

Participant Demographics

Subjects were mostly Caucasian, middle-aged adults, with a majority being obese and having a history of hyperlipidemia and hypertension.

Statistical Information

P-Value

P < .05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2010/820876

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication